Stock DNA
Commercial Services & Supplies
INR 13 Cr ()
10.00
21
0.00%
0.00
0.00%
1.79
Total Returns (Price + Dividend) 
Tradewell Hold for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Board Meeting Intimation for Intimation Of Board Meeting For Approval Of Unaudited Standalone Financial Results For The Quarter Ended June 30 2026
05-Aug-2026 | Source : BSETradewell Holdings Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday August 14 2026 at 03:00 P.M. at the Registered Office of the Company for the Quarter ended June 30 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08-Jul-2026 | Source : BSEPlease find attached herewith the Compliance certificate under reg 74(5) for the quarter ended on June 2026
Closure of Trading Window
29-Jun-2026 | Source : BSEEnclosed herewith is the closure of the trading window for the quarter ended 30th June 2026
Corporate Actions 
14 Aug 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Kamal Manchanda (48.02%)
Rashmi Gupta (9.5%)
21.18%
Quarterly Results Snapshot (Standalone) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 168.42% vs -99.27% in Mar 2025
YoY Growth in quarter ended Mar 2026 is -175.00% vs -68.70% in Mar 2025
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is -81.09% vs -69.73% in Mar 2025
YoY Growth in year ended Mar 2026 is 434.21% vs -115.38% in Mar 2025